Company Profile

Abeona Therapeutics is focused on developing and delivering gene therapy products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company's close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Epidermolysis Bullosa, Sanfilippo syndrome, Batten disease, and other rare disorders.

Latest Presentation

Contact Information

Investor Relations
Christine Silverstein
Senior Vice President, Finance & Investor Relations
T: +1 (646) 813-4707
csilverstein@abeonatherapeutics.com

Sofia Warner
Director, Investor Relations
T: +1 (646) 813-4710
swarner@abeonatherapeutics.com

Company Contact
Abeona Therapeutics, Inc.
1330 Avenue of the Americas
33rd Floor
New York, NY 10019